Pharmacological evaluation of BM-573, a dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, as potential anti-metastatic agent

Reference : Pharmacological evaluation of BM-573, a dual thromboxane A2 receptor antagonist and t...


	Document type :	Scientific congresses and symposiums : Paper published in a journal
	Discipline(s) :	Human health sciences : Pharmacy, pharmacology & toxicology
	To cite this reference:	http://hdl.handle.net/2268/21964

Title :	Pharmacological evaluation of BM-573, a dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, as potential anti-metastatic agent
Language :	English
Author, co-author :	De Leval, X. [> >]
	Dassesse, T. [> >]
	Benoit, V. [> >]
	Pirotte, Bernard [Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique >]
	David, Jean-Louis [Université de Liège - ULiège > > Médecine nucléaire - Hématologie clinique >]
	Merville, Marie-Paule [Université de Liège - ULiège > Département de pharmacie > Chimie médicale >]
	Castronovo, Vincenzo [Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie générale et cellulaire - GIGA-R : Labo de recherche sur les métastases >]
	Dogné, Jean-Michel [> >]
Publication date :	2003
Journal title :	Blood
Special issue title :	102
Pages :	72b
Peer reviewed :	Yes
Audience :	International
Permalink :	http://hdl.handle.net/2268/21964

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	abstract Blood 2003 3.pdf	No commentary	Publisher postprint	164.29 kB	Request copy

All documents in ORBi are protected by a user license.